Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS · Delayed Price · Currency is USD
0.0599
+0.0076 (14.53%)
Mar 9, 2026, 2:52 PM EST

PVCT Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
225040452323
Upgrade
Market Cap Growth
-51.22%25.33%-11.35%96.93%-1.55%-5.21%
Upgrade
Enterprise Value
255343482346
Upgrade
Last Close Price
0.050.120.100.110.060.06
Upgrade
PS Ratio
63.5981.7972.2145.94--
Upgrade
PB Ratio
-3.61-8.46-5.30-7.29-5.51-0.78
Upgrade
EV/Sales Ratio
70.3486.0577.2548.64--
Upgrade
Debt / Equity Ratio
-0.40-0.53-0.40-0.35-0.42-0.79
Upgrade
Net Debt / Equity Ratio
-0.38-0.48-0.39-0.35-0.25-0.78
Upgrade
Net Debt / EBITDA Ratio
-0.39-0.73-1.18-0.76-0.23-5.05
Upgrade
Net Debt / FCF Ratio
-0.70-0.88-1.15-0.71-1.05-5.80
Upgrade
Asset Turnover
0.570.500.320.36--
Upgrade
Quick Ratio
0.010.040.010.000.090.00
Upgrade
Current Ratio
0.040.140.150.230.450.01
Upgrade
Return on Assets (ROA)
-623.13%-200.92%-89.58%-64.62%-141.40%-298.62%
Upgrade
Return on Capital Employed (ROCE)
100.70%66.10%33.00%46.60%110.80%16.40%
Upgrade
Earnings Yield
-29.90%-9.44%-7.70%-7.82%-24.01%-28.50%
Upgrade
FCF Yield
--6.51%-6.39%-6.69%-4.39%-17.44%
Upgrade
Buyback Yield / Dilution
-0.16%-0.07%-0.01%-2.76%-3.81%-1.72%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.